Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, announced Tuesday it has entered into a definitive agreement to sell its miraDry business to 1315 Capital, a healthcare growth equity firm investing in commercial stage companies across medical devices, healthcare services, and therapeutics. “We are delighted to have found the best partner in 1315 Capital who has recognized the untapped potential of the miraDry business and is committed to serving and growing the current installed base of over 1,600 miraDry systems,” said Ron Menezes, President and Chief Executive Officer of Sientra.
Read the full article: Sientra Announces Sale of miraDry Business to 1315 Capital //
Source: https://www.globenewswire.com/news-release/2021/05/11/2227599/33599/en/Sientra-Announces-Sale-of-miraDry-Business-to-1315-Capital.html